01324-6/asset/4a54a807-9d4c-43b0-9cee-525570c8c25d/main.assets/gr2_lrg.jpg)
Quick Dispatch:
Your surpass cvot tirzepatide SURPASS CVOT orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your surpass cvot tirzepatide SURPASS CVOT ships.
Need Help?
Questions about surpass cvot tirzepatide SURPASS CVOT, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for surpass cvot tirzepatide SURPASS CVOT in your area.
Tirzepatide vs Dulaglutide for Cardiovascular Outcomes (SURPASS-CVOT) | NEJM
23.51
In the SURPASS-CVOT head-to-head trial involving over 13,000 adults with T2D and ASCVD, tirzepatide (Mounjaro) matched dulaglutide in reducing major cardiovascular events (8% lower risk) and significantly cut all-cause mortality by 16%
28.63
Frontiers
22.86
01774-X/asset/29980040-bf4f-4117-ad08-f431cfca3ffc/main.assets/gr3_lrg.jpg)
Efficacy and safety of tirzepatide in children and adolescents with type 2 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, phase 3 trial
21.15
💡 New insight in diabetes care: In patients with T2DM and ASCVD, the SURPASS-CVOT trial found that tirzepatide was noninferior to dulaglutide for major cardiovascular events (12.2% vs 13.1%; HR 0.92). What
27.64
AHA 25: SURPASS-CVOT:Tirzepatide vs Dulaglutide for Heart Failure in T2D
25.59
Tirzepatide vs Dulaglutide in T2D: SURPASS-CVOT
23.51
